{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:18:30Z","timestamp":1790677110481,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.urology.2015.01.009","type":"journal-article","created":{"date-parts":[[2015,3,27]],"date-time":"2015-03-27T17:14:37Z","timestamp":1427476477000},"page":"856-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Efficacy of Dapoxetine for the Treatment of Premature Ejaculation: A Meta-analysis of Randomized Clinical Trials on Intravaginal Ejaculatory Latency Time, Patient-reported Outcomes, and Adverse Events"],"prefix":"10.1016","volume":"85","author":[{"given":"Fa-Gui","family":"Yue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2015.01.009_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CE.S13841","article-title":"Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation","volume":"7","author":"McCarty","year":"2012","journal-title":"Core Evid"},{"key":"10.1016\/j.urology.2015.01.009_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/1756287212453866","article-title":"Dapoxetine: a new option in the medical management of premature ejaculation","volume":"4","author":"McMahon","year":"2012","journal-title":"Ther Ady Urol"},{"key":"10.1016\/j.urology.2015.01.009_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.urology.2015.01.009_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"1 Pt 1","key":"10.1016\/j.urology.2015.01.009_bib5","first-page":"256","article-title":"Treatment of premature ejaculation in the Asia-Pacific region: results from a phase III double-blind, parallel-group study of dapoxetine","volume":"7","author":"McMahon","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2015.01.009_bib6","first-page":"2312","article-title":"Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study","volume":"10","author":"McMahon","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2015.01.009_bib7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.eururo.2009.01.025","article-title":"Dapoxetine for the treatment of premature ejaculation: results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries","volume":"55","author":"Buvat","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2015.01.009_bib8","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1464-410X.2008.08165.x","article-title":"Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial","volume":"103","author":"Kaufman","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2015.01.009_bib9","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(06)69373-2","article-title":"Efficacy and tolerability of dapoxetine in treatment of premature ejaculation: an integrated analysis of two double-blind, randomised controlled trials","volume":"368","author":"Pryor","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.urology.2015.01.009_bib10","first-page":"524","article-title":"Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials","volume":"8","author":"McMahon","year":"2011","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2015.01.009_bib11","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1464-410X.2008.07845.x","article-title":"Perceived control over ejaculation is central to treatment benefit in men with premature ejaculation: results from phase III trials with dapoxetine","volume":"102","author":"Shabsigh","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2015.01.009_bib12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/sj.npp.1301500","article-title":"Safety and efficacy of dapoxetine in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study","volume":"33","author":"Safarinejad","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.urology.2015.01.009_bib13","first-page":"2231","article-title":"Baseline characteristics and treatment outcomes for men with acquired or lifelong premature ejaculation with mild or no erectile dysfunction: integrated analysis of two phase 3 dapoxetine trials","volume":"7","author":"Porst","year":"2010","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2015.01.009_bib14","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2605.2011.01243.x","article-title":"A\u00a0prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation","volume":"35","author":"Pastore","year":"2012","journal-title":"Int J Androl"},{"key":"10.1016\/j.urology.2015.01.009_bib15","first-page":"2832","article-title":"Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: prospective, randomized, double-blind, placebo-controlled, multicenter study","volume":"10","author":"Lee","year":"2013","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2015.01.009_bib16","first-page":"1259","article-title":"Selective serotonin reuptake inhibitor-induced sexual dysfunction","volume":"6","author":"Corona","year":"2009","journal-title":"J\u00a0Sex Med"},{"key":"10.1016\/j.urology.2015.01.009_bib17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/bmj.330.7488.396","article-title":"Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials","volume":"330","author":"Fergusson","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.urology.2015.01.009_bib18","first-page":"2707","article-title":"Oral agents for treatment of premature ejaculation: review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation","volume":"8","author":"McMahon","year":"2011","journal-title":"J\u00a0Sex Med"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429515000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T04:54:35Z","timestamp":1537764875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429515000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0090429515000357"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2015.01.009","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Dapoxetine for the Treatment of Premature Ejaculation: A Meta-analysis of Randomized Clinical Trials on Intravaginal Ejaculatory Latency Time, Patient-reported Outcomes, and Adverse Events","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2015.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}